Literature DB >> 575904

The identification and clinical implications of human breast milk mitogen.

D Tapper, M Klagsbrun, J Neumann.   

Abstract

There are constituents of human breast milk that make it superior to cow's milk for the nutrition, health and development of human infants. We have discovered a new activity in breast milk. We have found in human breast milk a nitrogen that stimulates DNA synthesis and induces division in cells grown in culture. This mitogenic activity is concentration dependent, and also depends on time since lactation. No similar mitogenic activity is found in commercially available formulas or cows milk 1 wk after birthing. The human milk mitogen might be involved in the growth and development of cells in the neonate. It may be important in preventing necrotizing entercolitis and peptic ulceration of the newborn. It might also be used in the treatment of infants following massive small bowel resection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 575904     DOI: 10.1016/s0022-3468(79)80270-5

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Human milk in the management of protracted diarrhoea of infancy.

Authors:  P I Macfarlane; V Miller
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

2.  Studies on the growth-stimulatory activity of pigeon milk--comparison and synergistic effects with serum.

Authors:  L Bharathi; K B Shenoy; M Mojamdar; S N Hegde
Journal:  J Comp Physiol B       Date:  1993       Impact factor: 2.200

3.  Development of secretory immunity in breast fed and bottle fed infants.

Authors:  S Stephens
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

4.  Human colostrum contains an activity that inhibits the production of IL-2.

Authors:  J W Hooton; H F Pabst; D W Spady; V Paetkau
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 5.  Mucosal immunity: the immunology of breast milk.

Authors:  H B Slade; S A Schwartz
Journal:  J Allergy Clin Immunol       Date:  1987-09       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.